ReviewThe Korean journal of helicobacter and upper gastrointestinal research2025
Artificial Intelligence in Upper Gastrointestinal Diagnosis.
Review in The Korean journal of helicobacter and upper gastrointestinal research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Artificial Intelligence for Endoscopic Diagnosis of Gastric Premalignant Lesions.The Korean journal of helicobacter and upper gastrointestinal research · 2026Review
- Artificial Intelligence for the Detection of Small Bowel Lesions and Neoplasia: A Scoping Review.Cureus · 2026Review
- Applications of Large Language Models in Medical Research: From Systematic Reviews to Clinical Studies.Bioengineering (Basel, Switzerland) · 2026Review
- Artificial intelligence-driven gastrointestinal functional assessment: multimodal imaging, digital biomarkers, and real-time monitoring.Frontiers in physiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) has revolutionized upper gastrointestinal (GI) endoscopy by enhancing the detection, characterization, and management of GI diseases. In this review, we explore the transformative role of AI technologies, including machine learning and deep learning, in improving diagnostic accuracy and streamlining clinical workflows. AI systems such as convolutional neural networks have shown remarkable potential for identifying subtle lesions, assessing tumor margins, and reducing interobserver variability. By providing real-time decision-making support, AI minimizes unnecessary biopsies and improves patient outcomes. We also explore the applications of AI in detecting precancerous conditions such as Barrett's esophagus, atrophic gastritis, and gastric intestinal metaplasia, as well as its role in guiding therapy for early gastric cancer. Non-image-based AI tools such as Raman spectroscopy complement traditional imaging by offering molecular-level insights for real-time tissue characterization. Despite its promise, the adoption of AI in endoscopy faces challenges, including the need for robust validation, user-centric design, and targeted training for endoscopists. Concerns regarding overreliance and deskilling underscore the importance of balancing AI integration with the preservation of clinical expertise. Lastly, we examine the future of AI in upper GI diagnosis and how image-based and non-image-based AI technologies can be integrated to enable comprehensive diagnosis and personalized therapeutic planning. By addressing current limitations and fostering collaboration between clinicians and technologists, AI has the potential to redefine the standards of care for upper GI diagnosis and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.